Q2 FY2026 EarningsQ2 FY26 results beat consensus on both top and bottom lines: revenue $515.5M vs. $460.7M expected (+11.9%), and Normalized EPS $0.18 vs. $0.20 (inclusive of higher non-controlling interest impacts). Gross margin was 17.7% vs. the 17.1% consensus mean. The beat was primarily driven by U.S. Federal and Europe project timing. Management successfully closed the $400M Neogenyx biogas joint venture with HASI, providing $233.8M in immediate proceeds for deleveraging and growth.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Ameresco(AMRC) the Revenue is 515.46 M (+9.14%), Beat estimate;the EBIT is 44.15 M (+58.96%), Beat estimate;the EPS is 0.18 (-25%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.52B9.14%
0.46B2.45%
+0.05B11.59%
EBITExceed expectations
0.04B58.96%
0.03B18.70%
+0.01B40.26%
EPSExceed expectations
0.1825.00%
0.15834.19%
+0.02209.19%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf